Tradjenta

Type: Product
Name: Tradjenta
First reported 13 hours ago - Updated 13 hours ago - 1 reports

TRADJENTA (Linagliptin) Tablet, Film Coated [Cardinal Health]

First reported Jul 22 2014 - Updated Jul 22 2014 - 1 reports

TRADJENTA (Linagliptin) Tablet, Film Coated [Cardinal Health]

First reported Jul 16 2014 - Updated Jul 16 2014 - 1 reports

Following through on medicine safety concerns

The mother of an 8-month-old girl was given a prescription for her baby for amoxicillin 400 mg twice daily. Amoxicillin is an antibiotic commonly used to treat various ear, nose, throat, chest, and skin infections. When dropping off the prescription at ... [Published Philly.com - Jul 16 2014]
First reported Jul 09 2014 - Updated Jul 09 2014 - 1 reports

Insulin for Type 2

Doctors are starting people with Type 2 diabetes on insulin sooner, sometimes at diagnosis. But two recent studies give reason to question this treatment. If you have Type 2, is insulin right for you?The reason for starting insulin early is simple: Insulin ... [Published Diabetes Self-Management - Jul 09 2014]
First reported Jun 19 2014 - Updated Jun 19 2014 - 1 reports

Boehringer and Lilly re-file empagliflozin NDA with FDA

The US subsidiary of German family-owned drugmaker Boehringer Ingelheim and pharma major Eli Lilly (NYSE: LLY) have resubmitted a New Drug Application for the investigational sodium glucose co-transporter-2 (SGLT2) inhibitor empagliflozin for the treatment ... [Published Pharma Letter - Jun 19 2014]
First reported Jun 18 2014 - Updated Jun 18 2014 - 1 reports

June 19 - Diabetes Medication

GOOD MORNING DELMARVA - In addition to healthy eating, being at a normal weight and being active, medications play an important role in the management of diabetes. It's important to emphasize medications alone will not control diabetes, but taking them ... [Published WMDT ABC-47 - Jun 18 2014]
First reported Jun 16 2014 - Updated Jun 17 2014 - 2 reports

Two phase III trials of empagliflozin/linagliptin combo tablet showed reduction in blood glucose levels in adults withT2D

Two phase III clinical trials found the investigational combination tablet of empagliflozin and linagliptin reduced blood glucose levels in adults with type 2 diabetes (T2D), Boehringer Ingelheim Pharmaceuticals, Inc. (BIPI) and Eli Lilly and Company ... [Published PharmaBiz - Jun 17 2014]
First reported Jun 15 2014 - Updated Jun 16 2014 - 1 reports

Type 2 Diabetes: Investigational Empagliflozin/Linagliptin Combination Tablet Showed Reduction in Blood Glucose in Two Phase III Trials

- For those taking metformin, empagliflozin/linagliptin combination tablet showed statistically significant reductions in blood glucose vs. empagliflozin or linagliptin alone after 24 weeks - For treatment-naïve adults, empagliflozin 10 mg/linagliptin ... [Published Scottrade - Jun 15 2014]
First reported Apr 24 2014 - Updated Apr 24 2014 - 1 reports

Possible Link Between Heart Failure And Onglyza Diabetes Type 2 Drug Is Being Investigated By FDA, As Announced In February 2014

This Cardiovascular Side Effect Issue Also Involves Kombygilyze XR, A Saxagliptin - Metformin Combo Diabetes Medication (Posted by Tom Lamb at DrugInjuryWatch.com ) AstraZeneca's diabetes drugs Onglyza and Kombygilyze, both of which contain ... [Published Drug Injury Watch - Apr 24 2014]
First reported Apr 20 2014 - Updated Apr 21 2014 - 1 reports

TRADJENTA (Linagliptin) Tablet, Film Coated [Boehringer Ingelheim Pharmaceuticals, Inc.]

First reported Apr 16 2014 - Updated Apr 16 2014 - 1 reports

US FDA accepts NDA filing of empagliflozin and linagliptin combo drug to treat adults with type 2 diabetes

Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company announced that the US Food and Drug Administration (FDA) accepted the filing of the New Drug Application (NDA) for the investigational combination tablet of empagliflozin and linagliptin ... [Published PharmaBiz - Apr 16 2014]
First reported Mar 07 2014 - Updated Mar 07 2014 - 1 reports

What Do Pharma's "High Performers" Have in Common?

A new study of high-performing pharma companies reveals science-based innovation strategies and patient-outcome-based commercial models are now the key drivers of growth. Anne O’Riordan reports.A select group of high performing pharma companies are significantly ... [Published Pharmaceutical Executive - Mar 07 2014]

Quotes

...referenced in the complete response letter," said Paul Fonteyne, president and chief executive of Boehringer Ingelheim Pharmaceuticals Inc, adding: "We believe in the potential of empagliflozin and hope to provide another treatment option in the near future to adults with type 2 diabetes."
...0 per cent with the combination," said Christophe Arbet-Engels, vice president, metabolic clinical development and medical affairs, BIPI. "People with type 2 diabetes must often take more than one medication to adequately control their blood sugar levels. If approved, this combination tablet with two mechanisms of action that lower A1C through different pathways in a single pill could be an important treatment option for physicians and patients."
From the February 2014 "FDA Drug Safety Communication: FDA to review heart failure risk with diabetes drug saxagliptin (marketed as Onglyza and Kombiglyze XR)" Safety Announcement:
...said Christophe Arbet-Engels, vice president, metabolic-clinical development and medical affairs, Boehringer Ingelheim Pharmaceuticals, Inc. "Adults living with type 2 diabetes often take more than one therapy to manage their condition, and we hope the combination of these two products will help them improve control of their blood sugar."

More Content

All (20) | News (16) | Reports (0) | Blogs (4) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
TRADJENTA (Linagliptin) Tablet, Film Coated [Ca... [Published DailyMed Drug Label Updates for the last seven ... - 13 hours ago]
TRADJENTA (Linagliptin) Tablet, Film Coated [Ca... [Published DailyMed Drug Label Updates for the last seven ... - Jul 22 2014]
Following through on medicine safety concerns [Published Philly.com - Jul 16 2014]
Insulin for Type 2 [Published Diabetes Self-Management - Jul 09 2014]
Boehringer and Lilly re-file empagliflozin NDA ... [Published Pharma Letter - Jun 19 2014]
June 19 - Diabetes Medication [Published WMDT ABC-47 - Jun 18 2014]
Two phase III trials of empagliflozin/linaglipt... [Published PharmaBiz - Jun 17 2014]
Eli Lilly Impresses at American Diabetes Associ... [Published Zacks.com - Jun 16 2014]
Type 2 Diabetes: Investigational Empagliflozin/... [Published Scottrade - Jun 15 2014]
Possible Link Between Heart Failure And Onglyza... [Published Drug Injury Watch - Apr 24 2014]
TRADJENTA (Linagliptin) Tablet, Film Coated [Bo... [Published DailyMed Drug Label Updates for the last seven ... - Apr 20 2014]
US FDA accepts NDA filing of empagliflozin and ... [Published PharmaBiz - Apr 16 2014]
What Do Pharma's "High Performers" Have in Common? [Published Pharmaceutical Executive - Mar 07 2014]
The New Metrics of Market Success [Published Pharmaceutical Executive - Mar 03 2014]
Januvia Pancreatic Cancer Allegations Help: Res... [Published PRWeb - Feb 27 2014]
Januvia Pancreatic Cancer Allegations Alert: Re... [Published PRWeb - Jan 19 2014]
Byetta Pancreatic Cancer Allegations Attorneys:... [Published PRWeb - Dec 19 2013]
Byetta Pancreatic Cancer Allegation Attorneys: ... [Published PRWeb - Nov 27 2013]
Byetta Pancreatic Cancer Allegations Lawyers: R... [Published PRWeb - Nov 05 2013]
Latest Januvia Lawsuits Alleging Pancreatic Can... [Published PRWeb - Oct 14 2013]
1
In Focus
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
TRADJENTA (Linagliptin) Tablet, Film Coated [Ca... [Published DailyMed Drug Label Updates for the last seven ... - 13 hours ago]
Updated Date: Jul 22, 2014 EST ...
TRADJENTA (Linagliptin) Tablet, Film Coated [Ca... [Published DailyMed Drug Label Updates for the last seven ... - Jul 22 2014]
Updated Date: Jul 22, 2014 EST ...
Possible Link Between Heart Failure And Onglyza... [Published Drug Injury Watch - Apr 24 2014]
This Cardiovascular Side Effect Issue Also Involves Kombygilyze XR, A Saxagliptin - Metformin Combo Diabetes Medication (Posted by Tom Lamb at DrugInjuryWatch.com ) AstraZeneca's diabetes drugs Onglyza and Kombygilyze, both of which contain ...
TRADJENTA (Linagliptin) Tablet, Film Coated [Bo... [Published DailyMed Drug Label Updates for the last seven ... - Apr 20 2014]
Updated Date: Apr 15, 2014 EST ...
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.